Guabenxan

This classification denotes an antihypertensive agent with the molecular formula C10H13N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SAW16W26X6, chemically known as (1,4-benzodioxan-6-ylmethyl)guanidine but generally known as guabenxan, which bears US NIH Compound Identifier 28563. European Medicines Agency schedules Guabenxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07967MIG. The term GUABENXAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). GUABENXAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guabenxan under HS 29329985 and SITC 51569. As of Q4 2014, GUABENXAN remains the US FDA Preferred Term for this commodity. Guabenxan bears US NLM identifiers UMLS ID C0617438 and NCI Concept Code C65820. SMILES: C1COC2=C(O1)C=CC(=C2)CN=C(N)N.